Free Access
Volume 25, Number 2, Mars 2016
Page(s) 239 - 245
Section Mise Au Point / Update
Published online 17 February 2016
  • Squires RH Jr (2008) Acute liver failure in children. Semin Liver Dis 28:153–66 [CrossRef] [PubMed] [Google Scholar]
  • Sorkine P, Ben Abraham R, Szold O, et al (2001) Role of the molecular adsorbent recycling system (MARSTM) in the treatment of patients with acute exacerbation of chronic liver failure. Crit Care Med 29:1332–6 [CrossRef] [PubMed] [Google Scholar]
  • Wang MM, Chen SJ, Ye QF, et al (2008) Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China. Chin Med J (Engl) 121:2197–201 [PubMed] [Google Scholar]
  • Lee WS, McKiernan P, Kelly DA (2005) Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom. J Pediatr Gastroenterol Nutr 40:575–81 [CrossRef] [PubMed] [Google Scholar]
  • Bourgoin P, Merouani A, Phan V, et al (2014) Molecular Absorbent Recirculating System therapy (MARSTM(R)) in pediatric acute liver failure: a single center experience. Pediatr Nephrol 29:901–8 [CrossRef] [PubMed] [Google Scholar]
  • Brusilow SW (2002) Hyperammonemic encephalopathy. Medicine 81:240–9 [CrossRef] [PubMed] [Google Scholar]
  • Bjerring PN, Eefsen M, Hansen BA, et al (2009) The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema. Metabol Brain Dis 24:5–14 [CrossRef] [Google Scholar]
  • Squires RH, Jr., Shneider BL, Bucuvalas J, et al (2006) Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Ped 148:652–8 [CrossRef] [Google Scholar]
  • Cordoba J, Lopez-Hellin J, Planas M, et al (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41:38–43 [CrossRef] [PubMed] [Google Scholar]
  • Gluud LL, Dam G, Borre M, et al (2013) Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence ? Metabol Brain Dis 28:221–5 [CrossRef] [Google Scholar]
  • Acharya SK, Bhatia V, Sreenivas V, et al (2009) Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 136:2159–68 [CrossRef] [PubMed] [Google Scholar]
  • Simon-Talero M, Garcia-Martinez R, Torrens M, et al (2013) Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study. J Hepatol 59:1184–92 [CrossRef] [PubMed] [Google Scholar]
  • Malaguarnera M, Pistone G, Elvira R, et al (2005) Effects of L-carnitine in patients with hepatic encephalopathy. World J Gastroenterol 11:7197–202 [CrossRef] [PubMed] [Google Scholar]
  • Mumtaz K, Azam Z, Hamid S, et al (2009) Role of N-acetylcysteine in adults with non-acetaminophen-induced acute liver failure in a center without the facility of liver transplantation. Hepatol Int 3:563–70 [CrossRef] [PubMed] [Google Scholar]
  • Lee WM, Hynan LS, Rossaro L, et al (2009) Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 137:856–64 [CrossRef] [PubMed] [Google Scholar]
  • Mitzner SR, Stange J, Klammt S, et al (2009) Albumin dialysis MARSTM: knowledge from 10 years of clinical investigation. ASAIO journal 55:498–502 [CrossRef] [Google Scholar]
  • Stange J (2011) Extracorporeal liver support. Organogenesis 7:64–73 [CrossRef] [PubMed] [Google Scholar]
  • Schaefer B, Schmitt CP (2013) The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children. Pediatr Nephrol 28:1763–9 [CrossRef] [PubMed] [Google Scholar]
  • Auth MK, Kim HS, Beste M, et al (2005) Removal of metabolites, cytokines and hepatic growth factors by extracorporeal liver support in children. J Pediatr Gastroenterol Nutr 40:54–9 [CrossRef] [PubMed] [Google Scholar]
  • Novelli G, Rossi M, Morabito V, et al (2008) Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc 40:1921–4 [CrossRef] [PubMed] [Google Scholar]
  • Vaid A, Chweich H, Balk EM, et al (2012) Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO journal 58:51–9 [CrossRef] [Google Scholar]
  • Kantola T, Koivusalo AM, Hockerstedt K, et al (2008) The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transplant Int 21:857–66 [CrossRef] [Google Scholar]
  • Hessel FP, Bramlage P, Wasem J, et al (2010) Cost-effectiveness of the artificial liver support system MARSTM in patients with acute-on-chronic liver failure. Eur J Gastroenterol Hepatol 22:213–20 [CrossRef] [PubMed] [Google Scholar]
  • Bachli EB, Schuepbach RA, Maggiorini M, et al (2007) Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 27:475–84 [CrossRef] [PubMed] [Google Scholar]
  • Mitzner SR, Stange J, Klammt S, et al (2000) Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARSTM: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277–86 [CrossRef] [PubMed] [Google Scholar]
  • Heemann U, Treichel U, Loock J, et al (2002) Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 36:949–58 [CrossRef] [PubMed] [Google Scholar]
  • Hassanein TI, Tofteng F, Brown RS, Jr., et al (2007) Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 46:1853–62 [CrossRef] [PubMed] [Google Scholar]
  • Saliba F, Camus C, Durand F, et al (2013) Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 159:522–31 [CrossRef] [PubMed] [Google Scholar]
  • Rustom N, Bost M, Cour-Andlauer F, et al (2014) Effect of molecular adsorbents recirculating system treatment in children with acute liver failure caused by Wilson disease. J Pediatr Gastroenterol Nutr 58:160–4 [CrossRef] [PubMed] [Google Scholar]
  • Lexmond WS, Van Dael CML, Scheenstra R, et al (2015) Experience With Molecular Adsorbent Recirculating System Treatment in 20 Children Listed for High-Urgency Liver Transplantation. Liver Transpl 21:369–80 [CrossRef] [PubMed] [Google Scholar]
  • Schmidt LE, Wang LP, Hansen BA, et al (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9:290–7 [CrossRef] [PubMed] [Google Scholar]
  • Kantola T, Maklin S, Koivusalo AM, et al (2010) Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure. World J Gastroenterol 16:2227–34 [CrossRef] [PubMed] [Google Scholar]
  • Camus C, Lavoué S, Gacouin A, et al (2006) Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation. Intensive Care Med 32:1817–25 [CrossRef] [PubMed] [Google Scholar]
  • Bernel W, Wendon J (2013) Acute Liver Failure. New Engl J Med 369:2525–34 [Google Scholar]
  • Chevret L, Durand P, Lambert J, et al (2014) High-Volume Hemofiltration in Children With Acute Liver Failure. Pediatr Crit Care Med 15:e300–5 [CrossRef] [PubMed] [Google Scholar]
  • Tsipotis E, Shuja A, Jaber BL (2015) Albumin Dialysis for Liver Failure: A Systematic Review. Adv Chronic Kidney Dis 22:382–90 [CrossRef] [PubMed] [Google Scholar]
  • Vinsonneau C, Allain-Launay E, Blayau C, et al (2014) Épuration extrarénale en réanimation adulte et pédiatrique. Recommandations formalisées d’experts sous l’égide de la Société de réanimation de langue française (SRLF), avec la participation de la Société française d’anesthésie-réanimation (Sfar), du Groupe francophone de réanimation et urgences pédiatriques (GFRUP) et de la Société francophone de dialyse (SFD). Réanimation 23:714–37 [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.